These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33574286)

  • 21. 5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease.
    Chu JL; Bi SH; He Y; Ma RY; Wan XY; Wang ZH; Zhang L; Zheng MZ; Yang ZQ; Du LW; Maimaiti Y; Biekedawulaiti G; Duolikun M; Chen HY; Chen L; Li LL; Tie L; Lin J
    Front Endocrinol (Lausanne); 2022; 13():910907. PubMed ID: 35966076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of follicular lymphoma after treatment of diffuse large B-cell lymphoma: two case reports with review of literature.
    Xu P; Jiang Y; Guan C; Shao X; Chen M; Ouyang J; Chen B
    Int J Clin Exp Pathol; 2018; 11(1):324-332. PubMed ID: 31938115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era.
    Chen Y; Luo L; Chen L; Zheng X; Yang X; Zheng Z; Zheng J; Liu T; Yang T; Hu J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2311-2318. PubMed ID: 36219261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis.
    Hatipoğlu T; Esmeray Sönmez E; Hu X; Yuan H; Danyeli AE; Şeyhanlı A; Önal-Süzek T; Zhang W; Akman B; Olgun A; Özkal S; Alacacıoğlu İ; Özcan MA; You H; Küçük C
    Front Oncol; 2022; 12():870487. PubMed ID: 35795062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-hydroxymethylcytosine sequencing in plasma cell-free DNA identifies unique epigenomic features in prostate cancer patients resistant to androgen deprivation therapies.
    Li Q; Huang CC; Huang S; Tian Y; Huang J; Bitaraf A; Dong X; Nevalanen MT; Patel M; Wong J; Zhang J; Manley BJ; Park JY; Kohli M; Gore EM; Kilari D; Wang L
    medRxiv; 2024 Oct; ():. PubMed ID: 37904926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
    Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
    BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with
    Uryu H; Mishima Y; Tsuyama N; Yokoyama M; Nishimura N; Fukuta T; Shirouchi Y; Okabe T; Inoue N; Takeuchi K; Terui Y
    Leuk Lymphoma; 2021 Sep; 62(9):2141-2150. PubMed ID: 33749498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.
    Magnano L; Balagué O; Dlouhy I; Rovira J; Karube K; Pinyol M; Rivas-Delgado A; Costa D; Martínez-Trillos A; González-Farre B; Martínez-Pozo A; Giné E; Colomer D; Delgado J; Villamor N; Campo E; López-Guillermo A
    Ann Oncol; 2017 Nov; 28(11):2799-2805. PubMed ID: 29045517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
    Qu Z; Zhang T; Gao F; Gong W; Cui Y; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Li L; Wang X; Zhang H
    Biomed Res Int; 2022; 2022():4379556. PubMed ID: 35655476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma.
    Zhang F; Chen Y; Cui Q; Ge Y; Liu Y
    Discov Oncol; 2024 Apr; 15(1):129. PubMed ID: 38662249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component].
    Lin ZJ; Zha J; Yi SH; Li ZF; Ping LY; He XH; Yu HF; Zheng Z; Xu W; Chen FL; Xie Y; Chen BY; Zhang HL; Wang L; Ding KY; Li WY; Yang HY; Zhao WL; Qiu LG; Li ZM; Song YQ; Xu B
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):456-462. PubMed ID: 35968587
    [No Abstract]   [Full Text] [Related]  

  • 33. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients.
    Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED
    Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines.
    Cai Q; Zhang Z; Cui X; Zeng C; Cai J; Cai J; Wu K; Zhang X; Shi Y; Arvanitakis Z; Bissonnette MA; Chiu BC; Cheng SY; He C; Zhang W
    Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37387524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
    Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
    Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non-small cell lung cancer.
    Guler GD; Ning Y; Coruh C; Mognol GP; Phillips T; Nabiyouni M; Hazen K; Scott A; Volkmuth W; Levy S
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma.
    Stuckey R; Luzardo Henríquez H; de la Nuez Melian H; Rivero Vera JC; Bilbao-Sieyro C; Gómez-Casares MT
    World J Clin Oncol; 2023 Apr; 14(4):160-170. PubMed ID: 37124135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas.
    Cai J; Zeng C; Hua W; Qi Z; Song Y; Lu X; Li D; Zhang Z; Cui X; Zhang X; Yang Z; Zhang J; Quan K; Zhu W; Cai J; He C; Cheng SY; Zhang W; Mao Y
    Neurooncol Adv; 2021; 3(1):vdab049. PubMed ID: 34151267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of genome-wide 5-hydroxymethylation of blood samples stored in different anticoagulants: opportunities for the expansion of clinical resources for epigenetic research.
    Gao L; Zhang Z; Cui XL; West-Szymanski D; Ye C; He C; Zhang W; Bissonnette M
    Epigenetics; 2023 Dec; 18(1):2271692. PubMed ID: 37898998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.